Description     Claims     Drawing  

WO2009137391A2   [0004] 
US20040077595A   [0144] 
US473347   [0170] 
WO2007002433A   [0170]  [0243] 
WO2012109075A   [0212]  [0250] 
US7994185B   [0214] 
WO2011025927A   [0237] 

Nature   [0004] 
N Engl J Med   [0004] 
N Engl J Med   [0004] 
N Engl J Med   [0004] 
Lancet   [0004]  [0004] 
Nature   [0004]  [0004]  [0004] 
Bioorg Med Chem   [0004] 
Nature   [0004]  [0188]  [0188] 
Cell   [0004]  [0188]  [0188] 
Nature   [0004]  [0188] 
Arch Dermatol   [0004] 
Br J Dermatol   [0004] 
PROTECTIVE GROUPS IN ORGANIC CHEMISTRY   [0038] 
Tetrahedron   [0038] 
COMPENDIUM OF SYNTHETIC ORGANIC METHODS   [0038] 
CURRENT PROTOCOLS IN NUCLEIC ACID CHEMISTRY   [0038] 
Pharmaceutical Salts   [0042] 
Advanced Organic Chemistry: Reactions, Mechanisms and Structures   [0053] 
ADVANCED ORGANIC CHEMISTRY   [0054] 
Biochem. J   [0060] 
IUBMB Life   [0060] 
J. Nat Rev Cancer   [0060] 
Clin Adv. Hematol. Oncol.   [0060] 
Cancer Cell   [0060] 
Advanced Organic Chemistry; Reactions, Mechanisms and Structure   [0136] 
The Practice of Medicinal Chemistry   [0140] 
J. Med. Chem.   [0146] 
J Pharm Sci   [0146] 
Drug Dev. Res.   [0146] 
Remington's Pharmaceutical Sciences   [0152] 
The Science and Practice of Pharmacy   [0158] 
Clin Cancer Res.   [0172] 
Nat Genet.   [0173] 
PNAS   [0174] 
PLoS One   [0174] 
Science   [0175] 
Curr Pharm Des   [0175] 
Anticancer Drugs   [0175] 
J Biol Chem   [0178] 
Nature Cell Biol.   [0179] 
Neurosci Lett   [0179] 
Life Sci   [0179] 
J Cancer Res Clin Oncol   [0187] 
Trends Biochem Sci   [0188] 
Cell   [0188] 
Proc Natl Acad Sci U S A   [0188]  [0253]  [0268] 
The Journal of Cell Biology   [0249] 
International Journal of Cancer   [0249] 
Acta Crystallogr D Biol Crystallogr   [0268] 
Acta Crystallogr D Biol Crystallogr   [0268] 
Acta Crystallogr D Biol Crystallogr   [0268] 
Acta Crystallogr D Biol Crystallogr   [0268] 
Acta Crystallogr D Biol Crystallogr   [0268] 
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer   [0271] 
Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas   [0271] 
Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma   [0271] 
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma   [0271]